As expected, both mRNA and protein expression levels of METTL5 were significantly elevated in MM primary diagnosis (MM-PD) patient BM samples compared to MM complete response (MM-CR) patient BM samples (Fig. 1B, C, Supplementary Fig. 1G). The gene discussed is METTL5; the disease is Miyoshi myopathy.